Integrated Discovery & Development
Preclinical, API & Drug Discovery & Development
Syngene provides a broad spectrum of integrated discovery and development services right from early discovery including target identification & validation, lead generation & optimization and lead selection to development including preclinical development, API and drug product development for both small and large molecules.
We offer these services for various R&D programs from lead generation to clinical supplies of drug substance and drug product.
Further, for clinical development under Phase I, II & III, our Clinical Development Services division provides clinical research services fulfilling requirements of our clients. We also support our clients in drug filing with FDA and other global regulatory authorities.
While Syngene has a demonstrated experience in providing integrated discovery and development services to various global pharma/ biotech companies, we also provide customized solutions to our clients appropriate for their R&D programs from the service portfolio.
These services are available as both stand-alone services and as defined integrated activity bundles. Syngene also has cross-functional teams with multidisciplinary expertise for implementing integrated activities and has a consistent track record of managing and executing projects of diverse complexities.